Literature DB >> 7969748

Differential inhibition of soluble and membrane-bound acetylcholinesterase forms from mouse brain by choline esters with an acyl moiety of an intermediate size.

Y Cho1, S H Cha, D E Sok.   

Abstract

Differential inhibitions of soluble and membrane-bound acetylcholinesterase forms purified from mouse brain were examined by the comparison of kinetic constants such as a Km value, a Kss value (substrate inhibition constant), and IC50 values of active site-selective ligands including choline esters. Membrane-bound acetylcholinesterase form (solubilized only in the presence of detergent) showed lower Km and Kss values than soluble acetylcholinesterase form (easily solubilized without detergent). Edrophonium expressed a slightly but significantly (p < 0.01) higher inhibition of detergent-soluble acetylcholinesterase form than aqueous-soluble acetylcholinesterase form, while physostigmine inhibited both forms with a similar potency. A remarkable difference in inhibition was observed using choline esters; although choline esters with acyl chain of a short size (acetyl- to butyrylcholine) or a long size (heptanoyl- to decanoylcholine) showed a similar inhibitory potency for two forms of acetylcholinesterase, pentanoylcholine and hexanoylcholine inhibited more strongly aqueous-soluble acetylcholinesterase than detergent-soluble acetylcholinesterase. Thus, it is suggested that the two forms of AChE may be distinguished kinetically by pentanoyl- or hexanoylcholine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969748     DOI: 10.1007/BF00967447

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  19 in total

1.  Potentiation effect of choline esters on choline-catalysed decarbamoylation of dimethylcarbamoyl-acetylcholinesterase.

Authors:  Y B Kim; C H Jung; S J Choi; W J Seo; S H Cha; D E Sok
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

2.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

3.  Molecular forms of acetylcholinesterase in bovine caudate nucleus and superior cervical ganglion: solubility properties and hydrophobic character.

Authors:  J Grassi; M Vigny; J Massoulié
Journal:  J Neurochem       Date:  1982-02       Impact factor: 5.372

4.  Spectroscopic studies on acetylcholinesterase: influence of peripheral-site occupation on active-center conformation.

Authors:  H A Berman; W Becktel; P Taylor
Journal:  Biochemistry       Date:  1981-08-04       Impact factor: 3.162

5.  Preferential inhibition of acetylcholinesterase molecular forms in rat brain.

Authors:  N Ogane; E Giacobini; E Messamore
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

6.  Kinetic, equilibrium, and spectroscopic studies on dealkylation ("aging") of alkyl organophosphonyl acetylcholinesterase. Electrostatic control of enzyme topography.

Authors:  H A Berman; M M Decker
Journal:  J Biol Chem       Date:  1986-08-15       Impact factor: 5.157

7.  Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain.

Authors:  M Hallak; E Giacobini
Journal:  Neuropharmacology       Date:  1989-03       Impact factor: 5.250

8.  Differential inhibition of acetylcholinesterase molecular forms in normal and Alzheimer disease brain.

Authors:  N Ogane; E Giacobini; R Struble
Journal:  Brain Res       Date:  1992-09-04       Impact factor: 3.252

9.  Molecular forms and solubility of acetylcholinesterase during the embryonic development of rat and human brain.

Authors:  F Muller; Y Dumez; J Massoulié
Journal:  Brain Res       Date:  1985-04-08       Impact factor: 3.252

10.  Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system.

Authors:  J R Atack; E K Perry; J R Bonham; J M Candy; R H Perry
Journal:  J Neurochem       Date:  1986-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.